Freeport-McMoRan Inc
NYSE:FCX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
36.66
54.86
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Freeport-McMoRan Inc
Wall Street
Price Targets
FCX Price Targets Summary
Freeport-McMoRan Inc
According to Wall Street analysts, the average 1-year price target for
FCX
is 55.55 USD
with a low forecast of 35.47 USD and a high forecast of 65.1 USD.
FCX Last Price Targets
Freeport-McMoRan Inc
The latest public price target was made on Oct 8, 2024 by
Orest Wowkodaw
from
Scotiabank
,
who expects
FCX
stock to
rise by 36%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Orest Wowkodaw
Scotiabank
|
53
USD
Upside 36% |
2 months ago
Oct 8, 2024
|
Freeport-McMoRan price target raised to $53 from $52 at Scotiabank
TheFly
|
|
Orest Wowkodaw
Scotiabank
|
52
USD
Upside 34% |
2 months ago
Sep 30, 2024
|
Freeport-McMoRan downgraded to Sector Perform from Outperform at Scotiabank
TheFly
|
Carlos De Alba
Morgan Stanley
|
58
USD
Upside 49% |
3 months ago
Sep 19, 2024
|
Freeport-McMoRan price target lowered to $58 from $60 at Morgan Stanley
TheFly
|
Curt Woodworth
UBS
|
55
USD
Upside 41% |
3 months ago
Sep 4, 2024
|
UBS Upgrades Freeport-McMoRan (FCX) to Buy
StreetInsider
|
Brian MacArthur
Raymond James
|
53
USD
Upside 36% |
5 months ago
Jul 24, 2024
|
Freeport-McMoRan price target lowered to $53 from $54 at Raymond James
TheFly
|
|
Carlos De Alba
Morgan Stanley
|
62
USD
Upside 59% |
6 months ago
Jun 21, 2024
|
Morgan Stanley Upgrades Freeport-McMoRan (FCX) to Overweight
StreetInsider
|
|
Curt Woodworth
UBS
|
54
USD
Upside 39% |
7 months ago
May 14, 2024
|
Freeport-McMoRan (FCX) PT Raised to $54 at UBS
StreetInsider
|
David Coleman
Argus Research
|
54
USD
Upside 39% |
8 months ago
Apr 25, 2024
|
Freeport-McMoRan (FCX) PT Raised to $54 at Argus
StreetInsider
|
|
Orest Wowkodaw
Scotiabank
|
55
USD
Upside 41% |
8 months ago
Apr 9, 2024
|
Freeport-McMoRan price target raised to $55 from $48 at Scotiabank
TheFly
|
Liam Fitzpatrick
Deutsche Bank
|
46
USD
Upside 18% |
8 months ago
Apr 4, 2024
|
Freeport-McMoRan price target raised to $46 from $44 at Deutsche Bank
TheFly
|
|
Brian MacArthur
Raymond James
|
49.5
USD
Upside 27% |
8 months ago
Apr 3, 2024
|
Freeport-McMoRan (FCX) PT Raised to $49.50 at Raymond James
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FCX's stock price target?
Price Target
55.55
USD
According to Wall Street analysts, the average 1-year price target for
FCX
is 55.55 USD
with a low forecast of 35.47 USD and a high forecast of 65.1 USD.
What is Freeport-McMoRan Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Freeport-McMoRan Inc's revenue is
6%.
The projected
CAGR
for the next 4 years is
7%.
What is Freeport-McMoRan Inc's Operating Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Freeport-McMoRan Inc's operating income for the next 4 years is
13%.
What is Freeport-McMoRan Inc's Net Income forecast?
Projected CAGR
9%
The
compound annual growth rate
of Freeport-McMoRan Inc's net income for the next 4 years is
9%.
You don't have any saved screeners yet
